Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lidija Soelkner
Observed names:
L Soelkner,
L. Soelkner
Institution:
Austrian Breast & Colorectal Cancer Study Group
Observed institutions:
Medical University of Graz,
Paracelsus Medical University,
Comprehensive Cancer Center Vienna,
Nanostring Technologies (United States),
German Breast Group,
Austrian Breast & Colorectal Cancer Study Group,
Medical University of Vienna
show all 7
OpenAlex ID:
A5082285486
Impact of Breast Surgery in Primary Metastasized Breast Cancer
2018
·
Florian Fitzal
, Vesna Bjelic-Radisic
, et al.
·
Annals of Surgery
·
214
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
2021
·
Michael Gnant
, Florian Fitzal
, et al.
·
New England Journal of Medicine
·
159
PDF
Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial
2020
·
on behalf of the ABCSG
, V. Bjelic-Radisic
, et al.
·
BMC Cancer
·
51
PDF
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
2025
·
E. Agostinetto
, G. Pfeiler
, et al.
·
ESMO Open
·
7
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109)
2024
·
Guilherme Nader-Marta
, Christian Singer
, et al.
·
Breast Cancer Research
·
7
PDF
Addition of the MUC-1 vaccine tecemotide to neoadjuvant systemic therapy for patients with early breast cancer: Survival results from the prospective randomized ABCSG 34 trial.
2024
·
Christian F. Singer
, Dominik Hlauschek
, et al.
·
Journal of Clinical Oncology
·
6
Primary operation in synchroneous metastasized invasive breast cancer patients: First oncologic outcomes of the prospective randomized phase III ABCSG 28 POSYTIVE trial.
2017
·
Florian Fitzal
, Marija Balic
, et al.
·
Journal of Clinical Oncology
·
6
Abstract PS3-03: Vaccination with MUC-1-targeting tecemotide improves Survival of patients receiving neo-adjuvant chemotherapy for early breast cancer: Results from the Prospective Randomized ABCSG 34 Trial
2025
·
Christian F. Singer
, Dominik Hlauschek
, et al.
·
Clinical Cancer Research
·
2
Abstract PS3-11-06: Long-term prognostic and predictive value of lobular histology in the PALLAS trial
2026
·
G. Nader-Marta
, C. Desmedt
, et al.
·
Clinical Cancer Research
·
1
Abstract P2-02-04: De-escalation of bone-targeted treatment: Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
2023
·
Ana-Alicia Beltran-Bless
, Mark Clemons
, et al.
·
Cancer Research
LM02-trial perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases.
2020
·
Gudrun Piringer
, Thomas Gruenberger
, et al.
·
Journal of Clinical Oncology
Abstract P1-17-05: The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer
2019
·
Y Devyatko
, M Filipits
, et al.
·
Cancer Research
Primary surgery versus no surgery in synchronous metastastic breast cancer: Patient-reported outcomes of the ABCSG 28 Posytive trial.
2017
·
Vesna Bjelic-Radisic
, Florian Fitzal
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
13
Citation count:
453
H-index:
6
I10-index:
3
Year
Topic
Type
